| 1 |
Oculis Holding AG |
66,440.76 Bn |
66,440.47 Bn |
- |
7.14% |
| 2 |
Nanobiotix |
1,909.20 Bn |
1,909.14 Bn |
- |
- |
| 3 |
Akari Therapeutics |
1,009.43 Bn |
1,009.43 Bn |
- |
- |
| 4 |
BeOne Medicines |
468.28 Bn |
463.49 Bn |
1.35 Bn |
356.73% |
| 5 |
Vertex Pharmaceuticals |
122.49 Bn |
115.24 Bn |
2.59 Bn |
74.39% |
| 6 |
Regeneron Pharmaceuticals |
70.26 Bn |
61.51 Bn |
3.31 Bn |
3.23% |
| 7 |
Belite Bio |
62.88 Bn |
62.88 Bn |
- |
- |
| 8 |
Argenx Se |
55.67 Bn |
50.48 Bn |
1.41 Bn |
- |
| 9 |
Alnylam Pharmaceuticals |
37.37 Bn |
34.36 Bn |
959.66 Mn |
158.60% |
| 10 |
Caris Life Sciences |
4.41 Bn |
3.59 Bn |
214.23 Mn |
204.91% |
